Both in Pharmaceuticals
Clene vs Heron Therapeutics
Over the past year CLNN returned −62.5% and HRTX returned −73.8%; their daily moves had a correlation of 0.02.
CLNN −62.5% HRTX −73.8%Growth of $1, one year, split-adjusted
| Metric | CLNN | HRTX |
|---|---|---|
| Price | $4.10 | $0.2986 |
| Market cap | $58.3M | $56.7M |
| Today | +8.75% | +4.88% |
| 1 month | +5.9% | −10.0% |
| 6 months | −42.7% | −77.2% |
| Year to date | −30.2% | −77.0% |
| 1 year | −65.8% | −74.7% |
| Revenue growth (YoY) | +233.3% | +1.3% |
| Gross margin | 60.0% | 69.3% |
| Net margin | −14915.6% | −14.6% |
| P/E (TTM) | — | — |
| Price / sales | 295.8× | 0.4× |
| Net cash | -$9.1M | -$100.0M |
| Dividend yield | — | — |
| Volatility (60d) | 77.9% | 88.0% |
| Short % of float | 4.6% | 25.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).